search
Back to results

Use of Erythromycin in Mustard-Induced Bronchiolitis

Primary Purpose

Bronchiolitis Obliterans, Acute Obliterating Bronchiolitis

Status
Completed
Phase
Phase 4
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Erythromycin
Sponsored by
Baqiyatallah Medical Sciences University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bronchiolitis Obliterans

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)Male

Inclusion Criteria: Documented chemical exposure Clinical, spirometric and radiological findings were compatible with BO on High Resolution Computed Tomography (HRCT) Non-responsiveness to high dose bronchodilator therapy Exclusion Criteria: Radiographic evidence of pneumonia, active tuberculosis, lung carcinoma, or an infection that necessitated the use of an antibiotic History of cigarette smoking and occupational exposure to toxic agents of hypersensitivity to macrolides History of treatment with a systemic antibiotic within 7 days before the start of the study Any investigational medicine within 4 weeks of the study History of antibiotic injection within 6 weeks before the study Concomitant Theophylline or Carbamazepine, unless their serum concentrations were regularly monitored Patients who were in the exacerbation phase of their respiratory complications Need to use medications interact with macrolides such as Digoxin, Theophylline and Carbamazepine Systemic antibiotics Systemic Corticosteroids Admission to the hospital Abnormal kidney or liver function

Sites / Locations

  • Baqiyatallah Medical Sciences University

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
August 21, 2006
Last Updated
November 4, 2008
Sponsor
Baqiyatallah Medical Sciences University
search

1. Study Identification

Unique Protocol Identification Number
NCT00367419
Brief Title
Use of Erythromycin in Mustard-Induced Bronchiolitis
Official Title
Low-Dose Long-Term Prescription of Erythromycin in Mustard-Induced Bronchiolitis Obliterans
Study Type
Interventional

2. Study Status

Record Verification Date
March 2006
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Baqiyatallah Medical Sciences University

4. Oversight

5. Study Description

Brief Summary
We looked for the effectiveness of low-dose long-term prescription of erythromycin in mustard-induced bronchiolitis obliterans

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bronchiolitis Obliterans, Acute Obliterating Bronchiolitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
Double
Allocation
Randomized

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Erythromycin

10. Eligibility

Sex
Male
Eligibility Criteria
Inclusion Criteria: Documented chemical exposure Clinical, spirometric and radiological findings were compatible with BO on High Resolution Computed Tomography (HRCT) Non-responsiveness to high dose bronchodilator therapy Exclusion Criteria: Radiographic evidence of pneumonia, active tuberculosis, lung carcinoma, or an infection that necessitated the use of an antibiotic History of cigarette smoking and occupational exposure to toxic agents of hypersensitivity to macrolides History of treatment with a systemic antibiotic within 7 days before the start of the study Any investigational medicine within 4 weeks of the study History of antibiotic injection within 6 weeks before the study Concomitant Theophylline or Carbamazepine, unless their serum concentrations were regularly monitored Patients who were in the exacerbation phase of their respiratory complications Need to use medications interact with macrolides such as Digoxin, Theophylline and Carbamazepine Systemic antibiotics Systemic Corticosteroids Admission to the hospital Abnormal kidney or liver function
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mostafa Ghanei, Professor
Organizational Affiliation
Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran
Official's Role
Study Director
Facility Information:
Facility Name
Baqiyatallah Medical Sciences University
City
Tehran
ZIP/Postal Code
19945-546
Country
Iran, Islamic Republic of

12. IPD Sharing Statement

Learn more about this trial

Use of Erythromycin in Mustard-Induced Bronchiolitis

We'll reach out to this number within 24 hrs